Recall Record

Plymouth, MN, United States

Abbott recalls

14 recalls recorded since 2018, most recently on 10 September 2025. 5 are listed as ongoing. Status and classification are as published by the FDA.

Recalls14
Ongoing (FDA)5
Terminated or completed9
Class I (FDA)3

Ongoing Class I Medical devices

Recall started
10 September 2025
Reason
Abbott has become aware of a limited number of tip detachment events during catheter removal from the packaging.
Distribution
Worldwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0112-2026, Z-0110-2026, Z-0109-2026, Z-0113-2026, Z-0111-2026

Ongoing Class II Medical devices

Recall started
17 March 2025
Reason
Device may have a small breach in the proximal end of the shaft under the strain relief of the delivery system. Breach is not visibly detectable and may lead to prolonged procedure, blood loss, or air ingress with potential for air embolism.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1643-2025, Z-1644-2025

Ongoing Class II Medical devices

Recall started
4 March 2024
Reason
Customer complaints were received regarding falsely elevated results for some patient samples. Internal studies with customer return samples confirmed potential interactions that may lead to falsely elevated results when processed as below on the same instrument: " ARCHITECT Syphilis TP (LN 8D06) and/or ARCHITECT AdviseDx SARS-CoV-2-IgG II (LN 6S60) precedes ARCHITECT Anti-HCV testing (LN 1L79). " Alinity i Syphilis TP (LN 07P60) precedes Alinity i Anti-HCV testing (LN 08P05).
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1479-2024, Z-1480-2024

Ongoing Class II Medical devices

Recall started
28 September 2023
Reason
Certain NT2000iX RF generators were serviced using a tool that was subsequently found to be out of tolerance and therefore may not have provided accurate results for potential capacitance failure.
Distribution
US, Taiwan, and Colombia
Initiated
Voluntary: Firm initiated
Recall number
Z-0209-2024

Ongoing Class I Medical devices

Recall started
12 June 2023
Reason
There is an overall reported incidence rate of 0.77% related to observed or potential air embolism during procedures in which the ASDS product was used.
Distribution
Worldwide distribution - US Nationwide and the countries of Slovakia, Czech Republic.
Initiated
Voluntary: Firm initiated
Recall number
Z-2110-2023

Terminated Class II Medical devices

Recall started
9 June 2022
Terminated
14 August 2026
Reason
When connected to the EnSite Precision Navigation System, an affected TactiCath Contact Force Ablation Catheter, Sensor Enabled may present the error message: "invalid catheter,, or "expired catheter."
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1344-2022

Terminated Class II Medical devices

Recall started
28 April 2022
Terminated
18 June 2024
Reason
Incorrect product labeling.
Distribution
US Nationwide Distribution to states of: MO, CA, OH, WA and OUS internationally to Italy and Netherlands.
Initiated
Voluntary: Firm initiated
Recall number
Z-1213-2022

Terminated Class II Medical devices

Recall started
24 March 2022
Terminated
4 August 2026
Reason
Devices were manufactured with a "First Use Date" preprogrammed in the EEPROM which disables the use of the single-use device.
Distribution
Worldwide distribution - US Nationwide - there was government distribution but no military. The countries of Austria, Belgium, Canada, Denmark, France, Germany, Greece, Israel, Italy, Japan, Netherlands, Norway, Palestine, Poland, Portugal, Russia, Slovakia, Spain, Sweden, Taiwan, and United Kingdom
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0957-2022, Z-0956-2022

Terminated Class II Medical devices

Recall started
16 November 2021
Terminated
18 June 2024
Reason
As a result of a manufacturing error, one (1) lot of Ultimum Hemostasis Introducer devices was manufactured with an incorrect hub and overall length. The devices manufactured were 12 cm in length instead of the intended 5 cm in length.
Distribution
Worldwide distribution - US Nationwide distribution in the state of Missouri and the country of Australia.
Initiated
Voluntary: Firm initiated
Recall number
Z-0420-2022

Terminated Class II Medical devices

Recall started
9 November 2021
Terminated
7 August 2024
Reason
Instructions for use were updated.
Distribution
OUS distribution only
Initiated
Voluntary: Firm initiated
Recall number
Z-0895-2022

Terminated Class II Medical devices

Recall started
22 May 2020
Terminated
11 February 2021
Reason
High rate of reported complaints for the loss of contact force information while using the TactiCath Quartz Contact Force Ablation Catheter
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2541-2020

Terminated Class II Medical devices

Recall started
28 February 2020
Terminated
18 April 2024
Reason
Internal testing of software identified software anomaly scenarios where if non-applicable shock energy value is selected, the device will continue to use the previously programmed energy level and the user will not be alerted that the selected value was not retained.
Distribution
U.S. AK, Al, AR, AZ, CA, CO, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MO, MS, NC, ND, NE, NH, NJ, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, and WV. OUS: None - the firm stated that there are no OUS consignees associated to ICDs that were interrogated from January 22, 2020 to
Initiated
Voluntary: Firm initiated
Recall number
Z-1700-2020

Terminated Class II Medical devices

Recall started
19 November 2018
Terminated
28 April 2021
Reason
The device is unable to pair with the mobile app due to the device incorrectly determining the certificate has expired.
Distribution
US Nationwide Distribution in the states of AZ, CA, CO, ID, IL, LA, MA, MI, MO, NE, NH, NJ, NY, TN, TX, and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1220-2019

Terminated Class I Medical devices

Recall started
5 April 2018
Terminated
15 October 2021
Reason
Reports of outflow graft twist occlusions. Patients whose devices experience outflow graft occlusions will experience a persistent low flow alarm. Outflow graft occlusions can result in serious adverse events such as hemodynamic compromise, thrombus, and death.
Distribution
Worldwide Distribution -- U.S., including the states of MN, PA, IL, WI, AZ, AR, TN, MO, TX, MA, NE, MI, CA, NC, OH, NY, GA, VA, FL, OK, MD, ME, SC, IN, LA, OR, WA, AL, CO, IA, KS, KY, UT, DC, and CT; and, the countries of Australia, Austria, Belgium, Brazil, Brunei, Canada, Cayman Islands, Colombia,
Initiated
Voluntary: Firm initiated
Recall number
Z-1774-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.